NasdaqGM - Nasdaq Real Time Price USD

Cronos Group Inc. (CRON)

2.0300
-0.0200
(-0.98%)
At close: May 23 at 4:00:00 PM EDT
2.0300
0.00
(0.00%)
After hours: May 23 at 7:45:46 PM EDT
Loading Chart for CRON
  • Previous Close 2.0500
  • Open 2.0300
  • Bid 2.0100 x 2600
  • Ask 2.0500 x 2600
  • Day's Range 2.0000 - 2.0400
  • 52 Week Range 1.6000 - 2.6900
  • Volume 1,292,771
  • Avg. Volume 1,774,758
  • Market Cap (intraday) 782.401M
  • Beta (5Y Monthly) 1.52
  • PE Ratio (TTM) 14.50
  • EPS (TTM) 0.1400
  • Earnings Date Aug 6, 2025 - Aug 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.94

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.

thecronosgroup.com

459

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON

View More

Performance Overview: CRON

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CRON
4.10%
S&P/TSX Composite index (^GSPTSE)
5.12%

1-Year Return

CRON
23.11%
S&P/TSX Composite index (^GSPTSE)
16.57%

3-Year Return

CRON
36.16%
S&P/TSX Composite index (^GSPTSE)
28.13%

5-Year Return

CRON
69.70%
S&P/TSX Composite index (^GSPTSE)
73.53%

Compare To: CRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    775.86M

  • Enterprise Value

    -60.14M

  • Trailing P/E

    14.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.25

  • Price/Book (mrq)

    0.73

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    39.69%

  • Return on Assets (ttm)

    -2.42%

  • Return on Equity (ttm)

    4.59%

  • Revenue (ttm)

    124.59M

  • Net Income Avi to Common (ttm)

    49.44M

  • Diluted EPS (ttm)

    0.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    837.82M

  • Total Debt/Equity (mrq)

    0.16%

  • Levered Free Cash Flow (ttm)

    -28.78M

Research Analysis: CRON

View More

Company Insights: CRON

Research Reports: CRON

View More

People Also Watch